September 13, 2016
Sophia Genetics and Illumina Sign Co-Marketing Agreement to Speed Adoption of Next-Generation Sequencing (NGS) in Clinical Diagnostics

September 8, 2016
Chrono Therapeutics Raises $47.6 Million in Series B Financing to Advance its Clinical Platform for Personalized Drug Therapy. Kaiser Permanente Ventures Leads Round

June 27, 2016
Quid named a Tech Pioneer by World Economic Forum

May 17, 2016
EndoStim Names Rohan Hoare, Ph.D., as New President and CEO

May 12, 2016
EndoStim Secures $25 Million in Funding to Expand Commercialization Efforts and Conduct a Pivotal U.S. Clinical Trial

Endeavour Vision SA 2006-2016 Terms & Conditions